{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:07:38Z","timestamp":1793333258085,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institutes of Health, United States","award":["U54EB007958-17"],"award-info":[{"award-number":["U54EB007958-17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00736-1","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T03:40:26Z","timestamp":1743046826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Increasing Access To Sexually Transmitted Infection Testing: The Promise of Point-of-Care and Over-the-Counter Tests"],"prefix":"10.1007","volume":"22","author":[{"given":"Stephany","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Osburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari C.","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"736_CR1","unstructured":"Sexually Transmitted Infections Surveillance. U.S. Centers for Disease Control and Prevention. 2023. Available from: https:\/\/www.cdc.gov\/sti-statistics\/annual\/summary.html"},{"key":"736_CR2","unstructured":"Sexually Transmitted Infections National Strategic Plan for the United States: . U.S. Department of Health and Human Services.: Washington, DC. 2020;2021\u20132025"},{"key":"736_CR3","unstructured":"Sexually transmitted infections: adopting a sexual health paradigm. National Academies of Sciences, Engineering, and Medicine. 2021."},{"issue":"4","key":"736_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1473-3099(21)00448-5","volume":"22","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, et al. Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis. 2022;22(4):541\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"736_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/QAD.0000000000003163","volume":"36","author":"J Jarolimova","year":"2022","unstructured":"Jarolimova J, et al. Curable sexually transmitted infections among women with HIV in sub-Saharan Africa. Aids. 2022;36(5):697\u2013709.","journal-title":"Aids"},{"key":"736_CR6","unstructured":"Global health sector strategy on sexually transmitted infections. World Health Organization. 2021;2016\u20132021."},{"key":"736_CR7","doi-asserted-by":"crossref","unstructured":"Cristillo AD et al. Point-of-Care Sexually Transmitted Infection Diagnostics: Proceedings of the STAR Sexually Transmitted Infection\u2014Clinical Trial Group Programmatic Meeting. Sexually Transmitted Diseases. 2017;44(4).","DOI":"10.1097\/OLQ.0000000000000572"},{"issue":"5","key":"736_CR8","doi-asserted-by":"publisher","first-page":"e0003226","DOI":"10.1371\/journal.pgph.0003226","volume":"4","author":"C Fortas","year":"2024","unstructured":"Fortas C, et al. Asymptomatic infections with chlamydia trachomatis, neisseria gonorrhoeae, and Trichomonas vaginalis among women in low- and middle-income countries: A systematic review and meta-analysis. PLOS Glob Public Health. 2024;4(5):e0003226.","journal-title":"PLOS Glob Public Health"},{"issue":"3","key":"736_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1039\/D1LC00665G","volume":"22","author":"K Hsieh","year":"2022","unstructured":"Hsieh K, et al. Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections. Lab Chip. 2022;22(3):476\u2013511.","journal-title":"Lab Chip"},{"issue":"1","key":"736_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrmicro794","volume":"2","author":"SR Galvin","year":"2004","unstructured":"Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004;2(1):33\u201342.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"736_CR11","doi-asserted-by":"publisher","first-page":"e25673","DOI":"10.1002\/jia2.25673","volume":"24","author":"JJ Ong","year":"2021","unstructured":"Ong JJ, et al. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review. J Int AIDS Soc. 2021;24(2):e25673.","journal-title":"J Int AIDS Soc"},{"key":"736_CR12","unstructured":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. WHO. 2022."},{"issue":"8s","key":"736_CR13","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1097\/OLQ.0000000000001457","volume":"48","author":"CA Gaydos","year":"2021","unstructured":"Gaydos CA, Manabe YC, Melendez JH. A narrative review of where we are with Point-of-Care sexually transmitted infection testing in the united States. Sex Transm Dis. 2021;48(8s):S71\u20137.","journal-title":"Sex Transm Dis"},{"issue":"8","key":"736_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/14737159.2020.1778467","volume":"20","author":"CA Gaydos","year":"2020","unstructured":"Gaydos CA, Melendez JH. Point-by-Point progress: gonorrhea point of care tests. Expert Rev Mol Diagn. 2020;20(8):803\u201313.","journal-title":"Expert Rev Mol Diagn"},{"issue":"11","key":"736_CR15","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.5858\/arpa.2020-0118-RA","volume":"144","author":"PC Adamson","year":"2020","unstructured":"Adamson PC, Loeffelholz MJ, Klausner JD. Point-of-Care testing for sexually transmitted infections: A review of recent developments. Arch Pathol Lab Med. 2020;144(11):1344\u201351.","journal-title":"Arch Pathol Lab Med"},{"key":"736_CR16","doi-asserted-by":"publisher","first-page":"e920873","DOI":"10.12659\/MSM.920873","volume":"26","author":"L Peng","year":"2020","unstructured":"Peng L, Chen JL, Wang D. Progress and perspectives in point of care testing for urogenital chlamydia trachomatis infection: A review. Med Sci Monit. 2020;26:e920873.","journal-title":"Med Sci Monit"},{"key":"736_CR17","unstructured":"Gonorrhea point-of-care diagnostics technology and market: Landscape report. 2024, Unitaid."},{"issue":"2","key":"736_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.idc.2023.02.002","volume":"37","author":"M Kahn","year":"2023","unstructured":"Kahn M, Van Der Pol B. Advances in diagnostics of sexually transmitted infections. Infect Dis Clin N Am. 2023;37(2):381\u2013403.","journal-title":"Infect Dis Clin N Am"},{"issue":"1","key":"736_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13690-021-00708-y","volume":"79","author":"M Murtagh","year":"2021","unstructured":"Murtagh M, et al. The relevance of target product profiles for manufacturers, experiences from the world health organization initiative for point-of-care testing for sexually transmitted infections. Arch Public Health. 2021;79(1):187.","journal-title":"Arch Public Health"},{"key":"736_CR20","unstructured":"The diagnostics landscape for sexually transmitted infections. 2023, World Health Organization."},{"key":"736_CR21","unstructured":"Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV. 2023, World Health Organization."},{"key":"736_CR22","unstructured":"Manabe YC. The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections. Clin Biochem. 2021."},{"issue":"2","key":"736_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1071\/SH14166","volume":"12","author":"CC Bristow","year":"2015","unstructured":"Bristow CC, et al. A review of recent advances in rapid point-of-care tests for syphilis. Sex Health. 2015;12(2):119\u201325.","journal-title":"Sex Health"},{"key":"736_CR24","unstructured":"Dual HIV\/syphilis rapid diagnostic tests can be used as the first test in antenatal care. 2019, World Health Organization."},{"issue":"S4","key":"736_CR25","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1136\/sextrans-2016-053067","volume":"93","author":"H Kelly","year":"2017","unstructured":"Kelly H, et al. Systematic reviews of point-of-care tests for the diagnosis of urogenital chlamydia trachomatis infections. Sex Transm Infect. 2017;93(S4):S22\u201330.","journal-title":"Sex Transm Infect"},{"issue":"10427","key":"736_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(23)02240-7","volume":"403","author":"RPH Peters","year":"2024","unstructured":"Peters RPH, et al. Novel lateral flow assay for point-of-care detection of neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation. Lancet. 2024;403(10427):657\u201364.","journal-title":"Lancet"},{"issue":"3","key":"736_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/OLQ.0000000000001913","volume":"51","author":"B Gleeson","year":"2024","unstructured":"Gleeson B, et al. Development of a novel Fluorescent-Based lateral flow assay for the detection of neisseria gonorrhoeae at the point of care. Sex Transm Dis. 2024;51(3):186\u201391.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"736_CR28","doi-asserted-by":"publisher","first-page":"e0264620","DOI":"10.1128\/JCM.02646-20","volume":"59","author":"EN Kersh","year":"2021","unstructured":"Kersh EN, et al. At-Home specimen Self-Collection and Self-Testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: a review of laboratory implementation issues. J Clin Microbiol. 2021;59(11):e0264620.","journal-title":"J Clin Microbiol"},{"key":"736_CR29","doi-asserted-by":"crossref","unstructured":"Trick AY et al. A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility. Sci Transl Med, 2021. 13(593).","DOI":"10.1126\/scitranslmed.abf6356"},{"issue":"9","key":"736_CR30","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/cid\/ciac371","volume":"75","author":"LT Allan-Blitz","year":"2022","unstructured":"Allan-Blitz LT, Adamson PC, Klausner JD. Resistance-Guided therapy for neisseria gonorrhoeae. Clin Infect Dis. 2022;75(9):1655\u201360.","journal-title":"Clin Infect Dis"},{"key":"736_CR31","unstructured":"Classify Your Medical Device. Food and Drug Administration. 2023. Available from: https:\/\/www.fda.gov\/medical-devices\/overview-device-regulation\/classify-your-medical-device"},{"key":"736_CR32","unstructured":"CLIA Categorizations. Food and Drug Administration. 2023. Available from: https:\/\/www.fda.gov\/medical-devices\/ivd-regulatory-assistance\/clia-categorizations"},{"issue":"5","key":"736_CR33","doi-asserted-by":"publisher","first-page":"e0031223","DOI":"10.1128\/jcm.00312-23","volume":"62","author":"L Smy","year":"2024","unstructured":"Smy L, Ledeboer NA, Wood MG. At-home testing for respiratory viruses: a minireview of the current landscape. J Clin Microbiol. 2024;62(5):e0031223.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"736_CR34","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/cid\/ciad025","volume":"76","author":"S Ma","year":"2023","unstructured":"Ma S, et al. Accelerating human immunodeficiency virus Self-Testing in the united States: A call to action. Clin Infect Dis. 2023;76(9):1678\u201380.","journal-title":"Clin Infect Dis"},{"key":"736_CR35","unstructured":"List of Prequalified In-vitro Diagnostic Products. World Health Organization. 2024."},{"issue":"S1","key":"736_CR36","doi-asserted-by":"publisher","first-page":"e25249","DOI":"10.1002\/jia2.25249","volume":"22","author":"H Ingold","year":"2019","unstructured":"Ingold H, et al. The Self-Testing AfRica (STAR) initiative: accelerating global access and scale-up of HIV self-testing. J Int AIDS Soc. 2019;22(S1):e25249.","journal-title":"J Int AIDS Soc"},{"key":"736_CR37","unstructured":"Sexually Transmitted Infections Treatment Guidelines. 2024; Available from: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/screening-recommendations.htm"},{"issue":"6","key":"736_CR38","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jemermed.2017.08.094","volume":"53","author":"SP Wilson","year":"2017","unstructured":"Wilson SP, et al. Reliable rapid assay for gonorrhea and chlamydia in the emergency department. J Emerg Med. 2017;53(6):890\u20135.","journal-title":"J Emerg Med"},{"issue":"5","key":"736_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nurpra.2020.01.006","volume":"16","author":"KM Fisk","year":"2020","unstructured":"Fisk KM, et al. Getting it right: the impact of Point-of-Care testing for gonorrhea and chlamydia in the urgent care setting. J Nurse Practitioners. 2020;16(5):388\u201393.","journal-title":"J Nurse Practitioners"},{"issue":"4","key":"736_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/OLQ.0000000000001586","volume":"49","author":"M Dawkins","year":"2022","unstructured":"Dawkins M, et al. Clinical integration of a highly accurate polymerase chain reaction Point-of-Care test can inform immediate treatment decisions for chlamydia, gonorrhea, and Trichomonas. Sex Transm Dis. 2022;49(4):262\u20137.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"736_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/OLQ.0000000000000438","volume":"43","author":"L May","year":"2016","unstructured":"May L, et al. A randomized controlled trial comparing the treatment of patients tested for chlamydia and gonorrhea after a rapid polymerase chain reaction test versus standard of care testing. Sex Transm Dis. 2016;43(5):290\u20135.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"736_CR42","doi-asserted-by":"publisher","first-page":"e204819","DOI":"10.1001\/jamanetworkopen.2020.4819","volume":"3","author":"B Van Der Pol","year":"2020","unstructured":"Van Der Pol B, et al. Evaluation of the performance of a Point-of-Care test for chlamydia and gonorrhea. JAMA Netw Open. 2020;3(5):e204819.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"736_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/OLQ.0000000000000865","volume":"45","author":"LE Widdice","year":"2018","unstructured":"Widdice LE, et al. Performance of the atlas genetics rapid test for chlamydia trachomatis and women\u2019s attitudes toward Point-Of-Care testing. Sex Transm Dis. 2018;45(11):723\u20137.","journal-title":"Sex Transm Dis"},{"issue":"Suppl 1","key":"736_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12879-024-09042-4","volume":"24","author":"M Cordioli","year":"2024","unstructured":"Cordioli M, et al. Clinic-based evaluation of the dual Xpert CT\/NG assay on the GeneXpert system for screening for extragenital chlamydial and gonococcal infections amongst men who have sex with men. BMC Infect Dis. 2024;24(1):224.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"736_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/sextrans-2017-053443","volume":"94","author":"LM Causer","year":"2018","unstructured":"Causer LM, et al. Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation. Sex Transm Infect. 2018;94(5):340\u20135.","journal-title":"Sex Transm Infect"},{"issue":"3","key":"736_CR46","doi-asserted-by":"publisher","first-page":"e91504","DOI":"10.1371\/journal.pone.0091504","volume":"9","author":"LM Causer","year":"2014","unstructured":"Causer LM, et al. A laboratory-based evaluation of four rapid point-of-care tests for syphilis. PLoS ONE. 2014;9(3):e91504.","journal-title":"PLoS ONE"},{"issue":"12","key":"736_CR47","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/01.olq.0000190092.59482.96","volume":"32","author":"J Schachter","year":"2005","unstructured":"Schachter J, et al. Vaginal swabs are the specimens of choice when screening for chlamydia trachomatis and neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis. 2005;32(12):725\u20138.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"736_CR48","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1128\/JCM.02387-08","volume":"47","author":"BJ Masek","year":"2009","unstructured":"Masek BJ, et al. Performance of three nucleic acid amplification tests for detection of chlamydia trachomatis and neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol. 2009;47(6):1663\u20137.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"736_CR49","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1128\/JCM.41.9.4395-4399.2003","volume":"41","author":"MA Shafer","year":"2003","unstructured":"Shafer MA, et al. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect chlamydia trachomatis and neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol. 2003;41(9):4395\u20139.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"736_CR50","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/01.OLQ.0000079048.11771.46","volume":"30","author":"YH Hsieh","year":"2003","unstructured":"Hsieh YH, et al. Preference among female army recruits for use of self-administrated vaginal swabs or urine to screen for chlamydia trachomatis genital infections. Sex Transm Dis. 2003;30(10):769\u201373.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"736_CR51","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1128\/JCM.00100-07","volume":"45","author":"CE Michel","year":"2007","unstructured":"Michel CE, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol. 2007;45(5):1395\u2013402.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"736_CR52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/00007435-200211000-00006","volume":"29","author":"J Knox","year":"2002","unstructured":"Knox J, et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of chlamydia trachomatis, neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis. 2002;29(11):647\u201354.","journal-title":"Sex Transm Dis"},{"issue":"2","key":"736_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.diagmicrobio.2016.07.018","volume":"86","author":"L Dize","year":"2016","unstructured":"Dize L, et al. Performance of self-collected penile-meatal swabs compared to clinician-collected urethral swabs for the detection of chlamydia trachomatis, neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium by nucleic acid amplification assays. Diagn Microbiol Infect Dis. 2016;86(2):131\u20135.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"736_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1099\/jmm.0.000428","volume":"66","author":"L Berry","year":"2017","unstructured":"Berry L, Stanley B. Comparison of self-collected meatal swabs with urine specimens for the diagnosis of chlamydia trachomatis and neisseria gonorrhoeae in men. J Med Microbiol. 2017;66(2):134\u20136.","journal-title":"J Med Microbiol"},{"issue":"2","key":"736_CR55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/sextrans-2012-050573","volume":"89","author":"MA Chernesky","year":"2013","unstructured":"Chernesky MA, et al. Self-collected swabs of the urinary meatus diagnose more chlamydia trachomatis and neisseria gonorrhoeae infections than first catch urine from men. Sex Transm Infect. 2013;89(2):102\u20134.","journal-title":"Sex Transm Infect"},{"issue":"10","key":"736_CR56","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/0956462416684693","volume":"28","author":"DV Ferrero","year":"2017","unstructured":"Ferrero DV, et al. Self-collected Glans\/meatal \u2018dry\u2019 swab specimen and NAAT technology detects chlamydia trachomatis and neisseria gonorrhoeae - implications for public policy changes. Int J STD AIDS. 2017;28(10):985\u201390.","journal-title":"Int J STD AIDS"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00736-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:05:29Z","timestamp":1769605529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00736-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00736-1","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"10 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Research reported in this publication was supported by the National Institute of Biomedical Imaging and Bioengineering under Award Numbers U54EB007958. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"YCM has received research grant support from Hologic, Cepheid, Roche, ChemBio. All authors have no conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"27"}}